日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51 同源重组缺陷与早期乳腺癌的治疗反应和生存率相关。

Llop-Guevara Alba, Pellegrino Benedetta, Pimentel Isabel, Villacampa Guillermo, Solinas Cinzia, Torres-Esquius Sara, Campanini Nicoletta, Simonetti Sara, Tommasi Chiara, Serra Olga, Corianò Matilde, Boggiani Daniela, Michiara Maria, Minari Roberta, Bortesi Beatrice, Rapacchi Elena, Dieci Maria Vittoria, Lambertini Matteo, Zoppoli Gabriele, Schirone Alessio, Casarini Chiara, Cretella Elisabetta, Cortesi Laura, Silini Enrico Maria, Saura Cristina, Willard-Gallo Karen, Boisson Anais, Musolino Antonino, Serra Violeta, Balmaña Judith, Cruz Cristina

SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy

意大利北部疫情中心地区癌症患者在新冠疫情第一波期间的SARS-CoV-2感染风险、COVID-19患病率和死亡率

Corianò, Matilde; Isella, Luca; Tommasi, Chiara; Pellegrino, Benedetta; Michiara, Maria; Boggiani, Daniela; Pucci, Francesca; Leonetti, Alessandro; Bizzoco, Sabrina; Affanni, Paola; Veronesi, Licia; Rapacchi, Elena; Serra, Olga; Sgargi, Paolo; Maglietta, Giuseppe; Musolino, Antonino

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents

RAD51 的功能性 HRD 可识别与基因功能丧失和对 DNA 损伤剂的反应相关的 BRCA1 VUS。

Casartelli, C; Tommasi, C; Lazzarin, A; Corianò, M; Tornali, C; Serra, O; Campanini, N; Gutiérrez-Enríquez, S; Sikokis, A; Zanoni, D; Minari, R; Bortesi, B; Michiara, M; Boggiani, D; Uliana, V; Llop-Guevara, A; Serra, V; Musolino, A; Pellegrino, B

Dawn of diverse shelled and carbonaceous animal microfossils at ~ 571 Ma

约5.71亿年前,多种带壳和含碳动物微体化石开始出现。

Morais, Luana; Freitas, Bernardo T; Fairchild, Thomas Rich; Clavijo Arcos, Rolando Esteban; Guillong, Marcel; Vance, Derek; de Campos, Marcelo Da Roz; Babinski, Marly; Pereira, Luiz Gustavo; Leme, Juliana M; Boggiani, Paulo C; Osés, Gabriel L; Rudnitzki, Isaac D; Galante, Douglas; Rodrigues, Fabio; Trindade, Ricardo I F

Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing

乳腺癌和卵巢癌的遗传基础:三十年来遗传易感性检测的方法和经验教训

Barili, Valeria; Ambrosini, Enrico; Bortesi, Beatrice; Minari, Roberta; De Sensi, Erika; Cannizzaro, Ilenia Rita; Taiani, Antonietta; Michiara, Maria; Sikokis, Angelica; Boggiani, Daniela; Tommasi, Chiara; Serra, Olga; Bonatti, Francesco; Adorni, Alessia; Luberto, Anita; Caggiati, Patrizia; Martorana, Davide; Uliana, Vera; Percesepe, Antonio; Musolino, Antonino; Pellegrino, Benedetta

Landscape dynamics and the Phanerozoic diversification of the biosphere

景观动态与显生宙生物圈多样化

Salles, Tristan; Husson, Laurent; Lorcery, Manon; Hadler Boggiani, Beatriz

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

生殖系BRCA突变在HER2阳性乳腺癌患者中的预后意义

Viansone, A; Pellegrino, B; Omarini, C; Pistelli, M; Boggiani, D; Sikokis, A; Uliana, V; Zanoni, D; Tommasi, C; Bortesi, B; Bonatti, F; Piacentini, F; Cortesi, L; Camisa, R; Sgargi, P; Michiara, M; Musolino, A

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

与 IDH1-R132H 突变相比,非 IDH1-R132H IDH1/2 突变与星形细胞瘤中 DNA 甲基化增加和生存率提高相关。

Tesileanu, C Mircea S; Vallentgoed, Wies R; Sanson, Marc; Taal, Walter; Clement, Paul M; Wick, Wolfgang; Brandes, Alba Ariela; Baurain, Jean Francais; Chinot, Olivier L; Wheeler, Helen; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Rudà, Roberta; Weller, Michael; McBain, Catherine; Reijneveld, Jaap; Enting, Roelien H; Caparrotti, Francesca; Lesimple, Thierry; Clenton, Susan; Gijtenbeek, Anja; Lim, Elizabeth; de Vos, Filip; Mulholland, Paul J; Taphoorn, Martin J B; de Heer, Iris; Hoogstrate, Youri; de Wit, Maurice; Boggiani, Lorenzo; Venneker, Sanne; Oosting, Jan; Bovée, Judith V M G; Erridge, Sara; Vogelbaum, Michael A; Nowak, Anna K; Mason, Warren P; Kros, Johan M; Wesseling, Pieter; Aldape, Ken; Jenkins, Robert B; Dubbink, Hendrikus J; Baumert, Brigitta; Golfinopoulos, Vassilis; Gorlia, Thierry; van den Bent, Martin; French, Pim J

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

一项评估艾立布林联合吉西他滨治疗局部晚期或转移性三阴性乳腺癌患者的II期临床研究(ERIGE试验)。临床和药物遗传学结果由意大利临床肿瘤研究组(GOIRC)提供。

Pellegrino, B; Cavanna, L; Boggiani, D; Zamagni, C; Frassoldati, A; Schirone, A; Caldara, A; Rocca, A; Gori, S; Piacentini, F; Berardi, R; Brandes, A A; Foglietta, J; Villa, F; Todeschini, R; Tognetto, M; Naldi, N; Bortesi, B; Montemurro, F; Ardizzoni, A; Boni, L; Musolino, A

Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

CDK4/6抑制剂在BRCA突变、雌激素受体阳性乳腺癌中的作用机制和临床疗效:病例报告和文献综述

Militello, Anna Maria; Zielli, Teresa; Boggiani, Daniela; Michiara, Maria; Naldi, Nadia; Bortesi, Beatrice; Zanelli, Paola; Uliana, Vera; Giuliotti, Sara; Musolino, Antonino